Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Added the Locations section listing Texas and UT Southwestern Medical Center as study sites, and updated the page revision to v3.3.3. Removed HHS Vulnerability Disclosure, as well as Texas Locations and UT Southwestern Medical Center entries, with a revision to v3.3.2.
    Difference
    0.3%
    Check dated 2025-12-23T21:33:03.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:33:05.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Removed the government funding and operating status notice displayed on the page, eliminating the banner that previously warned users about updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:51:48.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    No additions or deletions detected on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T20:45:44.000Z thumbnail image
  8. Check
    99 days ago
    Change Detected
    Summary
    - Page version updated to v3.2.0 - Added government operating-status notice and guidance on where to check status - Removed a specific genetic cancer resource entry (Thyroid gland undifferentiated carcinoma)
    Difference
    4%
    Check dated 2025-10-06T04:57:01.000Z thumbnail image
  9. Check
    106 days ago
    Change Detected
    Summary
    Page version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:56:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.